alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › designed

designed

3 studies tagged designed, dated 2018-07-24 to 2022-08-25. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly 2022-08-25
  2. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease 2020-06-01
  3. Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements 2018-07-24

Studies

3 studies carry this tag.

Date range

2018 to 2022

Top journals

  • Angewandte Chemie (International ed. in English) 1
  • Nature communications 1
  • The Biochemical journal 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Nature communications 2022-08-25 Treatments

    Amyloid self-assembly is linked to numerous devastating cell-degenerative diseases.

  2. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Biochemical journal 2020-06-01 Treatments

    Amyloid beta peptide (Aβ42) aggregation in the brain is thought to be responsible for the onset of Alzheimer's disease, an insidious condition without an effective treatment or cure.

  3. Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Angewandte Chemie (International ed. in English) 2018-07-24 Treatments

    Amyloid self-assembly is linked to the pathogenesis of Alzheimer's disease (AD) and type 2 diabetes (T2D), but so far, no anti-amyloid compound has reached the clinic.

All topic tags with their study counts